Chemical structure determination of DNA bases modified by active metabolites of lucidin-3-O-primeveroside

Chemical Research in Toxicology

Volumn 23, Issue 1, 2010, Pages 134-141

  Ishii, Yuji ^a   Okamura, Toshiya ^a   Inoue, Tomoki ^a   Fukuhara, Kiyoshi ^a   Umemura, Takashi ^a   Nishikawa, Akiyoshi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIACETOXY 2 ACETOXYMETHYLANTHRAQUINONE; ANTHRAQUINONE DERIVATIVE; BENZOYL PEROXIDE; DEOXYADENOSINE DERIVATIVE; DEOXYGUANOSINE DERIVATIVE; DNA BASE; LUCIDIN 3 O PRIMEVEROSIDE; LUCIDIN N6 2 DEOXYADENOSINE; LUCIDIN N6 2 DEOXYGUANOSINE; MUTAGENIC AGENT; QUINONE DERIVATIVE; RUBIADIN; UNCLASSIFIED DRUG;

ACETYLATION; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CARCINOGENESIS; CARCINOGENICITY; CHEMICAL MODIFICATION; CHEMICAL REACTION; CHEMICAL STRUCTURE; DIODE; DNA ADDUCT; DNA DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; GENOTOXICITY; LIQUID CHROMATOGRAPHY; MALE; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RAT; RUBIA; THYMUS;

ANIMALS; ANTHRAQUINONES; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANOSINE; DISACCHARIDES; DNA; DNA ADDUCTS; PLANT ROOTS; RUBIA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

RATTUS; RUBIA TINCTORUM;

EID: 75149178320     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx900314c     Document Type: Article

References (23)

1. Inoue, K., Yoshida, M., Takahashi, M., Shibutani, M., Takagi, H., Hirose, M., and Nishikawa, A. (2009) Induction of kidney and liver cancers by the natural food additive madder color in a two-year rat carcinogenicity study. Food Chem. Toxicol. 47, 184-191.
2. Kawasaki, Y., Goda, Y., and Yoshihira, K. (1992) The mutagenic constituents of Rubia tinctorum. Chem. Pharm. Bull. 40, 1504-1509.
3. Poginsky, B., Westendorf, J., Blomeke, B., Marquardt, H., Hewer, A., Grover, P. L., and Phillips, D. H. (1991) Evaluation of DNA-binding activity of hydroxyanthraquinones occurring in Rubia tinctorum L. Carcinogenesis 12, 1265-1271.
4. Moustacchi, E. (2000) DNA damage and repair: consequences on dose-responses. Mutat. Res. 464, 35-40.
5. Choi, J. Y., and Guengerich, F. P. (2005) Adduct size limits efficient and error-free bypass across bulky N2-guanine DNA lesions by human DNA polymerase eta. J. Mol. Biol. 352, 72-90.
6. Wei, D., Maher, V. M., McCormick, J. J. (1996) Site-specific excision repair of 1-nitrosopyrene-induced DNA adducts at the nucleotide level in the HPRT gene of human fibroblasts: effect of adduct conformation on the pattern of site-specific repair. 16, 3714-3719.
7. Falany, C. N. (1991) Molecular enzymology of human liver cytosolic sulfotransferases. Trends Pharmacol. Sci. 12, 255-259.
8. Lehner, A. F., Horn, J., and Flesher, J. W. (2004) Mass spectrometric analysis of 7-sulfoxymethyl-12-methylbenz[a]anthracene and related electrophilic polycyclic aromatic hydrocarbon metabolites. J. Mass. Spectrom. 39, 1366-1378.
9. Shibutani, S., Dasaradhi, L., Terashima, I., Banoglu, E., and Duffel, M. W. (1998) Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts. Cancer Res. 58, 647-653.
10. Punt, A., Delatour, T., Scholz, G., Schilter, B., van Bladeren, P. J., and Rietjens, I. M. (2007) Tandem mass spectrometry analysis of N2-(trans-isoestragol-3′-yl)-2′-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1′-hydroxyestragole. Chem. Res. Toxicol. 20, 991-998.
11. Borchert, P., Wislocki, P. G., Miller, J. A., and Miller, E. C. (1973) The metabolism of the naturally occurring hepatocarcinogen safrole to 1′-hydroxysafrole and the electrophilic reactivity of 1′-acetoxysa- frole. Cancer Res. 33, 575-589.
12. Drinkwater, N. R., Miller, E. C., Miller, J. A., and Pitot, H. C. (1976) Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′-hydroxyestragole in the mouse and mutagenicity of 1′- acetoxyestragole in bacteria. J. Natl. Cancer Inst. 57, 1323-1331.
13. Phillips, D. H., Reddy, M. V., and Randerath, K. (1984) 32P-postlabelling analysis of DNA adducts formed by electrophilic esters of the hepatocarcinogens 1′-hydroxysafrole and 1′-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues. Cancer Res. 45, 3096-3105.
14. Kim, H. Y., Cooper, M., Nechev, L. V., Harris, C. M., and Harris, T. M. (2001) Synthesis and characterization of nucleosides and oligonecleotides with benzo[a]pyren-6ylmethyl adduct at adenine N6 or guanine N2. Chem. Res. Toxicol. 14, 1306-1314.
15. Wang, J. J., Marchall, W. D., Frazer, D. G., Law, B., and Lewis, D. M. (2003) Characterization of DNA adducts from lung tissue of asphalt fume-exposed mice by nanoflow liquid chromatography quadrupole time-of -flight mass spectrometry. Anal. Biochem. 322, 79-88.
16. Beland, F. A., Churchwell, M. I., Von Tungeln, L. S., Chen, S., Fu, P. P., Culp, S. J., Schoket, B., Gyorffy, E., Minarovits, J., Poirier, M. C., Bowman, E. D., Weston, A., and Doerge, D. R. (2005) High-performance liquid chromatography electrospray ionization mass spectrometry for the detection and quantitation of benzo[a] pyrene-DNA adducts. Chem. Res. Toxicol. 18, 1306-1315.
17. Rodriguez, H., and Loechler, E. L. (1993) Mutational spectra of the (+)-anti-diol epoxide of benzo[a]pyrene in supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutational specificity and the extent of SOS enhancement of mutagenesis. Carcinogenesis 14, 373-383.
18. Rodriguez, H., and Loechler, E. L. (1993) Mutagenesis by the (+)-anti-diol epoxide of benzo[a]pyrene: what controls mutagenic specificity? Biochemistry 32, 373-383.
19. Seo, K. Y., Nagalingam, A., Tiffany, M., and Loechler, E. L. (2005) Mutagenesis strudies with four stereoisomeric N2-dG benzo[a]pyrene adducts in the identical 5′-CGC sequence used in NMR studies: G →T mutations dominate in each case. Mutagenesis 20, 441-448.
20. Zhao, B., Wang, J., Geacintow, N. E., and Wang, Z. (2006) Poleta, Polzeta and Rev1 together are required for G to T transversion mutations induced by the (+)-and (-)-trans-anti-BPDE-N2-dG DNA adducts in yeast cells. Chem. Res. Toxicol. 34, 417-425.
21. Broyde, S., Wang, L., Zhang, L., Rechkoblit, O., Geacintov, N. E., and Patel, D. J. (2008) DNA adduct structure-function relationships: comparing solution with polymerase structures. Chem. Res. Toxicol. 21, 45-52.
22. Shibutani, S., Fernandes, A., Suzuki, N., Zhou, L., Johnson, F., and Grollman, A. P. (1999) Mutagenesis of the N-(deoxyguanosine-8yl)-2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine DNA adduct in mammalian cells. Sequence context effects. J. Biol. Chem. 274, 27433-27438.
23. Blomeki, B., Poginsky, B., Schmutte, C., Marquardt, H., and Westen-dorf, J. (1992) Formation of genotoxic metabolites from anthraquinone glycosides, present in Rubia tinctorum L. Mutat. Res. 265, 263-272. TX900314C